80_FR_10165 80 FR 10128 - Submission for OMB Review; 30-Day Comment Request; Assessment of Oncology Nursing Education and Training in Low and Middle Income Countries (NCI) [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication."> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication." /> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication." />

80 FR 10128 - Submission for OMB Review; 30-Day Comment Request; Assessment of Oncology Nursing Education and Training in Low and Middle Income Countries (NCI)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 37 (February 25, 2015)

Page Range10128-10129
FR Document2015-03788

Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on July 8, 2014, Vol. 79, page 38542 and allowed 60-days for public comment. One public comment was received on July 9, 2014. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.

Federal Register, Volume 80 Issue 37 (Wednesday, February 25, 2015)
[Federal Register Volume 80, Number 37 (Wednesday, February 25, 2015)]
[Notices]
[Pages 10128-10129]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03788]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; Assessment of 
Oncology Nursing Education and Training in Low and Middle Income 
Countries (NCI)

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH), has 
submitted to the Office of Management and Budget (OMB) a request for 
review and approval of the information collection listed below. This 
proposed information collection was previously published in the Federal 
Register on July 8, 2014, Vol. 79, page 38542 and allowed 60-days for 
public comment. One public comment was received on July 9, 2014. The 
purpose of this notice is to allow an additional 30 days for public 
comment. The National Cancer Institute (NCI), National Institutes of 
Health, may not conduct or sponsor, and the respondent is not required 
to respond to, an information collection that has been extended, 
revised, or implemented on or after October 1, 1995, unless it displays 
a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project, contact: Annette Galassi, Center for Global Health, 
National Cancer Institute, 9609 Medical Center Dr., Rm. 3W250, 
Rockville, MD 20850 or call non-toll-free number 240-276-6632 or Email 
your request, including your address to: [email protected]. Formal 
requests for additional plans and instruments must be requested in 
writing.
    Proposed Collection: Assessment of Oncology Nursing Education and 
Training in Low and Middle Income Countries, 0925-NEW, National Cancer 
Institute (NCI), National Institutes of Health (NIH).
    Need and Use of Information Collection: This submission is a 
request for OMB to approve the Assessment of Oncology Nursing Education 
and Training in Low and Middle Income Countries (LMICs). NCI-Designated 
Cancer Centers have a range of international activities, some of which 
are funded by NCI, but many of which are not. These international 
activities may include oncology nursing education and training in 
LMICs, but the extent of these activities across cancer centers is 
unknown. The proposed assessment requests information about oncology 
nursing education and training projects including: descriptions of 
projects, partner organizations, types of activities, cost, and impact. 
The information will be collected annually. NCI's Center for Global 
Health (CGH) is in the process of developing its strategic plan for 
oncology nursing education in LMICs.

[[Page 10129]]

This information will help inform this strategic planning process and 
provide evidence to inform decisions on potential investments in grants 
for oncology nursing education in LMICs. Additionally, this information 
will be used in an online, interactive map that is being developed by 
CGH which will allow external organizations, such as cancer centers, to 
explore what projects are being done in which countries, which will 
facilitate collaborations and minimize duplication. The frequency of 
the data collection will be once per year although respondents may have 
more than one response if they have up to three projects.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 51.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                 Number of        Number of      Average burden
             Type of respondents                respondents/    responses per     per response     Total annual
                                                    year          respondent       (in hours)      burden hours
----------------------------------------------------------------------------------------------------------------
Directors of Nursing........................              68                3            15/60               51
----------------------------------------------------------------------------------------------------------------


    Dated: February 19, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2015-03788 Filed 2-24-15; 8:45 am]
BILLING CODE 4140-01-P



                                                    10128                     Federal Register / Vol. 80, No. 37 / Wednesday, February 25, 2015 / Notices

                                                    received within 30-days of the date of                     Need and Use of Information                          applications are essential to the
                                                    this publication.                                       Collection: The Division of Cancer                      administration of these training
                                                    FOR FURTHER INFORMATION CONTACT: To                     Epidemiology and Genetics (DCEG)                        programs as they enable OE to
                                                    obtain a copy of the data collection                    Office of Education (OE) administers a                  determine the eligibility and quality of
                                                    plans and instruments or request more                   variety of programs and initiatives to                  potential awardees; to assess their
                                                    information on the proposed project                     recruit pre-college through post-doctoral               potential as future scientists; to
                                                    contact: Jackie Lavigne, Office of                      educational level individuals into the                  determine where mutual research
                                                    Education, Division of Cancer                           Intramural Research Program to                          interests exist; and to make decisions
                                                    Epidemiology and Genetics, 9609                         facilitate their development into future                regarding which applicants will be
                                                    Medical Center Drive, MSC 9776,                         biomedical scientists. DCEG trains post-                proposed and approved for traineeship
                                                    Bethesda, MD 20892–9776 or call non-                    doctoral, doctoral candidates, graduate                 awards. In each case, completing the
                                                    toll-free number 240–376–7237 or Email                  and baccalaureate students, through full                application is voluntary, but in order to
                                                    your request, including your address to:                time fellowships, summer fellowships,                   receive due consideration, the
                                                    lavignej@mail.nih.gov. Formal requests                  and internships in preparation for                      prospective trainee is encouraged to
                                                    for additional plans and instruments                    research careers in cancer epidemiology                 complete all relevant fields. The
                                                    must be requested in writing.                           and genetics. The proposed information                  information is for internal use to make
                                                      Proposed Collection: Division of                      collection involves brief online                        decisions about prospective fellows and
                                                    Cancer Epidemiology and Genetics                        applications completed by applicants to                 students that could benefit from the
                                                    (DCEG) Fellowship Program and                           the full time and the summer fellowship                 DCEG program.
                                                    Summer Student Applications (NCI),                      programs. Full-time fellowships                           OMB approval is requested for 3
                                                    Existing Collection in Use without OMB                  include: Full-time Equivalents (FTE)                    years. There are no costs to respondents
                                                    Control Number, National Cancer                         and non-FTE fellowships for US                          other than their time. The total
                                                    Institute (NCI), National Institutes of                 citizens, permanent residents and                       estimated annualized burden hours are
                                                    Health (NIH).                                           international fellows. These                            175.

                                                                                                           ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                        Average
                                                                                                                                                                    Number of
                                                                                                                                                  Number of                           burden per     Total annual
                                                                      Form name                                Type of respondent                                 responses per
                                                                                                                                                 respondents                           response      burden hours
                                                                                                                                                                    respondent         (in hours)

                                                    Fellowship Program Application ...................   Full-time Fellows ...................              150                 1            30/60             75
                                                    Summer Program Application .......................   Summer Students .................                  300                 1            20/60            100



                                                      Dated: February 19, 2015.                             The National Cancer Institute (NCI),                    agalassi@mail.nih.gov. Formal requests
                                                    Karla Bailey,                                           National Institutes of Health, may not                  for additional plans and instruments
                                                    NCI Project Clearance Liaison, National                 conduct or sponsor, and the respondent                  must be requested in writing.
                                                    Institutes of Health.                                   is not required to respond to, an                         Proposed Collection: Assessment of
                                                    [FR Doc. 2015–03789 Filed 2–24–15; 8:45 am]             information collection that has been                    Oncology Nursing Education and
                                                    BILLING CODE 4140–01–P                                  extended, revised, or implemented on or                 Training in Low and Middle Income
                                                                                                            after October 1, 1995, unless it displays               Countries, 0925–NEW, National Cancer
                                                                                                            a currently valid OMB control number.                   Institute (NCI), National Institutes of
                                                    DEPARTMENT OF HEALTH AND                                   Direct Comments to OMB: Written                      Health (NIH).
                                                    HUMAN SERVICES                                          comments and/or suggestions regarding                     Need and Use of Information
                                                                                                            the item(s) contained in this notice,                   Collection: This submission is a request
                                                    National Institutes of Health                           especially regarding the estimated                      for OMB to approve the Assessment of
                                                                                                            public burden and associated response                   Oncology Nursing Education and
                                                    Submission for OMB Review; 30-Day                       time, should be directed to the: Office                 Training in Low and Middle Income
                                                    Comment Request; Assessment of                          of Management and Budget, Office of                     Countries (LMICs). NCI-Designated
                                                    Oncology Nursing Education and                          Regulatory Affairs, OIRA_submission@                    Cancer Centers have a range of
                                                    Training in Low and Middle Income                       omb.eop.gov or by fax to 202–395–6974,                  international activities, some of which
                                                    Countries (NCI)                                         Attention: NIH Desk Officer.                            are funded by NCI, but many of which
                                                    SUMMARY:   Under the provisions of                         Comment Due Date: Comments                           are not. These international activities
                                                    Section 3507(a)(1)(D) of the Paperwork                  regarding this information collection are               may include oncology nursing
                                                    Reduction Act of 1995, the National                     best assured of having their full effect if             education and training in LMICs, but
                                                    Institutes of Health (NIH), has submitted               received within 30-days of the date of                  the extent of these activities across
                                                    to the Office of Management and Budget                  this publication.                                       cancer centers is unknown. The
                                                    (OMB) a request for review and                          FOR FURTHER INFORMATION CONTACT: To                     proposed assessment requests
                                                    approval of the information collection                  obtain a copy of the data collection                    information about oncology nursing
asabaliauskas on DSK5VPTVN1PROD with NOTICES




                                                    listed below. This proposed information                 plans and instruments or request more                   education and training projects
                                                    collection was previously published in                  information on the proposed project,                    including: descriptions of projects,
                                                    the Federal Register on July 8, 2014,                   contact: Annette Galassi, Center for                    partner organizations, types of activities,
                                                    Vol. 79, page 38542 and allowed 60-                     Global Health, National Cancer Institute,               cost, and impact. The information will
                                                    days for public comment. One public                     9609 Medical Center Dr., Rm. 3W250,                     be collected annually. NCI’s Center for
                                                    comment was received on July 9, 2014.                   Rockville, MD 20850 or call non-toll-                   Global Health (CGH) is in the process of
                                                    The purpose of this notice is to allow an               free number 240–276–6632 or Email                       developing its strategic plan for
                                                    additional 30 days for public comment.                  your request, including your address to:                oncology nursing education in LMICs.


                                               VerDate Sep<11>2014   18:05 Feb 24, 2015   Jkt 235001   PO 00000   Frm 00085    Fmt 4703    Sfmt 4703   E:\FR\FM\25FEN1.SGM   25FEN1


                                                                                      Federal Register / Vol. 80, No. 37 / Wednesday, February 25, 2015 / Notices                                                             10129

                                                    This information will help inform this                                 allow external organizations, such as                        than one response if they have up to
                                                    strategic planning process and provide                                 cancer centers, to explore what projects                     three projects.
                                                    evidence to inform decisions on                                        are being done in which countries,                             OMB approval is requested for 3
                                                    potential investments in grants for                                    which will facilitate collaborations and                     years. There are no costs to respondents
                                                    oncology nursing education in LMICs.                                   minimize duplication. The frequency of                       other than their time. The total
                                                    Additionally, this information will be                                 the data collection will be once per year                    estimated annualized burden hours are
                                                    used in an online, interactive map that                                although respondents may have more                           51.
                                                    is being developed by CGH which will
                                                                                                                         ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                          Average bur-
                                                                                                                                                                      Number of         Number of          den per re-   Total annual
                                                                                            Type of respondents                                                      respondents/     responses per           sponse     burden hours
                                                                                                                                                                         year           respondent          (in hours)

                                                    Directors of Nursing .........................................................................................         68               3                15/60           51



                                                      Dated: February 19, 2015.                                            disorders marked by the disruption in                           • Therapeutic increases in patient
                                                    Karla Bailey,                                                          the pathways responsible for carrying                        HbF expression at lower viral titers than
                                                    NCI Project Clearance Liaison, National                                oxygen to red blood cells. Symptoms                          current direct transduction methods.
                                                    Institutes of Health.                                                  associated with these disorders include                         • Improved safety and reduced
                                                    [FR Doc. 2015–03788 Filed 2–24–15; 8:45 am]                            anemia, jaundice, and severe pain. It has                    toxicity as a result of erythroid-specific
                                                    BILLING CODE 4140–01–P                                                 been shown that mutations during the                         expression.
                                                                                                                           development of fetal to adult                                   Development Stage:
                                                                                                                           hemoglobin can contribute to a delay in                         • Early-stage
                                                    DEPARTMENT OF HEALTH AND                                               red blood cell maturity underlying                              • In vitro data available
                                                    HUMAN SERVICES                                                         sickle cell disease. As a result, there has                     • In vivo data available (animal)
                                                                                                                           been an increased focus on treatments                           Inventors: Jeffery L. Miller, Yuanwei
                                                    National Institutes of Health                                          that promote the induction of fetal                          T. Lee, Jaira F. de Vasconcellos, Colleen
                                                                                                                           hemoglobin (HbF) to improve clinical                         K. Byrnes (all of NIDDK)
                                                    Government-Owned Inventions;                                           symptoms and ameliorate the severity of                         Intellectual Property: HHS Reference
                                                    Availability for Licensing                                             the diseases. Researchers at the National                    No. E–249–2014/0—US Provisional
                                                    AGENCY:       National Institutes of Health,                           Institute of Diabetes and Digestive and                      Application No. 62/046,247 filed
                                                    HHS.                                                                   Kidney Diseases have identified                              September 5, 2014
                                                    ACTION:      Notice.                                                   methods of increasing fetal hemoglobin                          Related Technology: HHS Reference
                                                                                                                           by increasing the expression of Lin28 or                     No. E–456–2013/2—PCT Application
                                                    SUMMARY:   The inventions listed below                                 decreased expression of let-7 micro-                         No. PCT/US2013/067811 filed October
                                                    are owned by an agency of the U.S.                                     RNAs. The lead inventor and colleagues                       31, 2013, which published as WO 2014/
                                                    Government and are available for                                       have developed novel lentiviral                              200557 on December 18, 2014
                                                    licensing in the U.S. in accordance with                               expression vectors containing                                   Licensing Contact: Vince Contreras,
                                                    35 U.S.C. 209 and 37 CFR part 404 to                                   hemoglobin regulators under the control                      Ph.D.; 301–435–4711; contrerasv@
                                                    achieve expeditious commercialization                                  of erythroid-specific promoters that can                     mail.nih.gov
                                                    of results of federally-funded research                                be used to increase Hbf expression                              Collaborative Research Opportunity:
                                                    and development. Foreign patent                                        without affecting the maturity of red                        The National Institute of Diabetes and
                                                    applications are filed on selected                                     blood cells. In addition, they have                          Digestive and Kidney Diseases is
                                                    inventions to extend market coverage                                   found, through the use of tough decoy                        seeking statements of capability or
                                                    for companies and may also be available                                inhibition of Let-7 micro-RNAs, a                            interest from parties interested in
                                                    for licensing.                                                         selection of Let-7 genes with greater                        collaborative research to further
                                                    FOR FURTHER INFORMATION CONTACT:                                       involvement in HbF expression. This                          develop, evaluate or commercialize this
                                                    Licensing information and copies of the                                technology could lead to development                         technology. For collaboration
                                                    U.S. patent applications listed below                                  of novel HbF induction therapies that                        opportunities, please contact Marguerite
                                                    may be obtained by writing to the                                      reactivate and reduce the aberrant                           J. Miller at millermarg@niddk.nih.gov or
                                                    indicated licensing contact at the Office                              pathologies associated with human                            301–496–9003.
                                                    of Technology Transfer, National                                       sickle-cell anemia and beta thalassemia.                     T Cell-Based Adoptive Transfer
                                                    Institutes of Health, 6011 Executive                                      Potential Commercial Applications:                        Immunotherapy for Polyomavirus-
                                                    Boulevard, Suite 325, Rockville,                                          • Ex vivo and in vivo therapeutics for                    Associated Pathologies
                                                    Maryland 20852–3804; telephone: 301–                                   treatment of sickle-cell anemia and beta
                                                    496–7057; fax: 301–402–0220. A signed                                                                                                 Description of Technology: Available
                                                                                                                           thalassemias.
                                                    Confidential Disclosure Agreement will                                                                                              for licensing are methods to generate T
                                                                                                                              • Potential use in combination with                       cells responsive to multiple
asabaliauskas on DSK5VPTVN1PROD with NOTICES




                                                    be required to receive copies of the
                                                                                                                           other transduction methods for unique                        polyomaviruses. The resulting T cell
                                                    patent applications.
                                                                                                                           therapeutic strategies.                                      populations could be useful in treating
                                                    SUPPLEMENTARY INFORMATION:
                                                                                                                              Competitive Advantages:                                   immunosuppressed individuals with
                                                    Technology descriptions follow.
                                                                                                                              • Reduced production of symptom-                          polyomavirus infections or
                                                    HbF Induction Therapy for Sickle Cell                                  associated adult hemoglobin.                                 polyomavirus-associated pathologies
                                                    Disease and Thalassemias                                                  • Lin28 overexpression at defined                         such as Merkel cell carcinoma (MCC),
                                                      Description of Technology: Sickle cell                               stage of hematopoietic cell                                  polyomavirus-associated nephropathy
                                                    disease and thalassemia are hereditary                                 development.                                                 (PVAN), hemorrhagic cystitis,


                                               VerDate Sep<11>2014        19:36 Feb 24, 2015       Jkt 235001      PO 00000      Frm 00086       Fmt 4703      Sfmt 4703   E:\FR\FM\25FEN1.SGM   25FEN1



Document Created: 2015-12-18 13:08:41
Document Modified: 2015-12-18 13:08:41
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesComments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
ContactTo obtain a copy of the data collection plans and instruments or request more information on the proposed project, contact: Annette Galassi, Center for Global Health, National Cancer Institute, 9609 Medical Center Dr., Rm. 3W250, Rockville, MD 20850 or call non-toll-free number 240-276-6632 or Email
FR Citation80 FR 10128 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR